Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study will evaluate the safety and efficacy of three dose levels of SPI-1005 compared to placebo on vertigo, tinnitus and sensorineural hearing loss in 40 adults with Meniere\'s disease.
Epistemonikos ID: 797172461ad4dc4a28cff014b28caeabfb3a881c
First added on: May 12, 2024